Poor prognosis linked to BRCA1 mutations
Breast cancer patients have a lower chance of long-term survival if they carry an inherited mutation in the BRCA1 gene, according to research published in Breast Cancer Research this week. However, the poor prognosis associated with the mutated gene is mitigated by chemotherapy.
The breast cancer susceptibility genes, BRCA1 and BRCA2, were identified over eight years ago, but the best way of treating women who develop hereditary breast cancer associated with mutations in these genes is still not clear.
A team of researchers from McGill University in Montreal and the Memorial Sloan-Kettering Cancer Center in New York investigated how the prognosis of breast cancer was affected by mutations in BRCA1 and BRCA2, and by the administration of chemotherapy. They studied the clinical records of 496 women of Ashkenazi Jewish descent who underwent treatment for invasive breast cancer between 1980 and 1995. Their results suggest that physicians should take the presence of such mutations into account when they are making treatment decisions.
56 of the women studied carried at least one mutation in either the BRCA1 or the BRCA2 gene. 79 of the women died from their breast cancer within ten years of diagnosis.
The ten-year survival rates for women with BRCA1 mutations were worse than those without mutations (38% of carriers died compared with 14% of non-carriers). However, the presence of a BRCA1 mutation did not reduce long-term survival if the women were treated with chemotherapy. Risk factors other than the mutations are likely to cause a poor prognosis under these circumstances.
The ten-year survival rates for women with BRCA2 mutations did not differ to those of non-carriers. Also, administration of chemotherapy did not affect survival rates of women with BRCA2 mutations, but the authors acknowledge that the sample size is too small for definitive conclusions
Further studies are necessary to see if the type of chemotherapy used has an effect when these mutations are present.
The researchers say: "This study demonstrates that women with specific BRCA1/2 mutations who develop breast cancer are at increased risk from death from their disease, particularly if the mutation is in BRCA1."
Although other factors contributed to a poor prognosis, for example if breast cancer was first diagnosed when the women were under 50 years old or if the tumour was larger than 2cm upon diagnosis, mutations in BRCA1 predicted an increase in mortality even when these factors were taken into account (if chemotherapy was not given). It may be that chemotherapy is particularly effective for women who carry a BRCA1 mutation.
The risk for breast cancer in the unaffected breast was much higher for BRCA1/2 mutation carriers than non-carriers. However, the 10-year risk of cancer returning in the treated breast was no greater in women with the BRCA mutations than in women without. This may have implications for women who have to choose between bilateral mastectomy and breast conservation, however, a longer follow-up study is needed before women can be reliably advised.
For further information about this research, please contact Associate Professor William Foulkes by email at William.email@example.com
or by phone on 514-934-1934 x44121
Gemma Bradley | EurekAlert!
The most recent press releases about innovation >>>
Die letzten 5 Focus-News des innovations-reports im Überblick:
An international team of scientists has proposed a new multi-disciplinary approach in which an array of new technologies will allow us to map biodiversity and the risks that wildlife is facing at the scale of whole landscapes. The findings are published in Nature Ecology and Evolution. This international research is led by the Kunming Institute of Zoology from China, University of East Anglia, University of Leicester and the Leibniz Institute for Zoo and Wildlife Research.
Using a combination of satellite and ground data, the team proposes that it is now possible to map biodiversity with an accuracy that has not been previously...
Heatwaves in the Arctic, longer periods of vegetation in Europe, severe floods in West Africa – starting in 2021, scientists want to explore the emissions of the greenhouse gas methane with the German-French satellite MERLIN. This is made possible by a new robust laser system of the Fraunhofer Institute for Laser Technology ILT in Aachen, which achieves unprecedented measurement accuracy.
Methane is primarily the result of the decomposition of organic matter. The gas has a 25 times greater warming potential than carbon dioxide, but is not as...
Hydrogen is regarded as the energy source of the future: It is produced with solar power and can be used to generate heat and electricity in fuel cells. Empa researchers have now succeeded in decoding the movement of hydrogen ions in crystals – a key step towards more efficient energy conversion in the hydrogen industry of tomorrow.
As charge carriers, electrons and ions play the leading role in electrochemical energy storage devices and converters such as batteries and fuel cells. Proton...
Scientists from the Excellence Cluster Universe at the Ludwig-Maximilians-Universität Munich have establised "Cosmowebportal", a unique data centre for cosmological simulations located at the Leibniz Supercomputing Centre (LRZ) of the Bavarian Academy of Sciences. The complete results of a series of large hydrodynamical cosmological simulations are available, with data volumes typically exceeding several hundred terabytes. Scientists worldwide can interactively explore these complex simulations via a web interface and directly access the results.
With current telescopes, scientists can observe our Universe’s galaxies and galaxy clusters and their distribution along an invisible cosmic web. From the...
Temperature measurements possible even on the smallest scale / Molecular ruby for use in material sciences, biology, and medicine
Chemists at Johannes Gutenberg University Mainz (JGU) in cooperation with researchers of the German Federal Institute for Materials Research and Testing (BAM)...